AbbVie (ABBV) Other financing activities (2012 - 2026)
AbbVie (ABBV) reported Other financing activities of $2.0 million for Q1 2026, down 97.01% year-over-year from $67.0 million in Q1 2025, and down 95.56% on a QoQ basis from $45.0 million in Q4 2025.
AbbVie (ABBV) has 15 years of Other financing activities data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Other financing activities fell 97.01% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 88.0% YoY) and the FY2025 annual result came in at $68.0 million, up 19.3% from the prior year.
- Other financing activities fell to $2.0 million in Q1 2026 per ABBV's latest filing, from $45.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $99.0 million in Q1 2024 and bottomed at -$75.0 million in Q2 2024.
- The 5-year median for Other financing activities is $10.0 million (2022), against an average of $12.8 million.
- The widest annual swing landed in 2022, when Other financing activities slumped 650.0%; it then jumped 4400.0% in 2025.
- Tracing ABBV's Other financing activities over 5 years: stood at -$11.0 million in 2022, then soared by 536.36% to $48.0 million in 2023, then sank by 97.92% to $1.0 million in 2024, then jumped by 4400.0% to $45.0 million in 2025, then slumped by 95.56% to $2.0 million in 2026.
- Per Business Quant, the three latest ABBV Other financing activities figures stand at $2.0 million (Q1 2026), $45.0 million (Q4 2025), and -$9.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 45.00 Mn |
| Dec 31, 2025 | 45.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -35.00 Mn |
| Jun 30, 2025 | -35.00 Mn |
| Mar 31, 2025 | 67.00 Mn |
| Mar 31, 2025 | 67.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 32.00 Mn |
| Sep 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | -75.00 Mn |
| Jun 30, 2024 | -75.00 Mn |
| Mar 31, 2024 | 99.00 Mn |
| Mar 31, 2024 | 99.00 Mn |
| Dec 31, 2023 | 48.00 Mn |
| Dec 31, 2023 | 48.00 Mn |
| Jun 30, 2023 | -21.00 Mn |
| Jun 30, 2023 | -21.00 Mn |
| Mar 31, 2023 | 21.00 Mn |
| Mar 31, 2023 | 21.00 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 21.00 Mn |
| Mar 31, 2022 | 21.00 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 21.00 Mn |
| Sep 30, 2021 | 21.00 Mn |
| Jun 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 5.00 Mn |
| Mar 31, 2021 | -4.00 Mn |
| Mar 31, 2021 | -4.00 Mn |
| Dec 31, 2020 | -20.00 Mn |
| Dec 31, 2020 | -20.00 Mn |
| Sep 30, 2020 | 8.00 Mn |
| Sep 30, 2020 | 8.00 Mn |
| Jun 30, 2020 | -5.00 Mn |
| Jun 30, 2020 | -5.00 Mn |
| Mar 31, 2020 | 25.00 Mn |
| Mar 31, 2020 | 25.00 Mn |
| Dec 31, 2019 | -1.00 Mn |
| Dec 31, 2019 | -1.00 Mn |
| Sep 30, 2019 | 15.00 Mn |
| Sep 30, 2019 | 15.00 Mn |
| Mar 31, 2019 | 21.00 Mn |
| Mar 31, 2019 | 21.00 Mn |
| Dec 31, 2018 | -2.00 Mn |
| Dec 31, 2018 | -2.00 Mn |
| Sep 30, 2018 | 11.00 Mn |
| Sep 30, 2018 | 11.00 Mn |
| Jun 30, 2018 | -32.00 Mn |
| Jun 30, 2018 | -32.00 Mn |
| Mar 31, 2018 | 37.00 Mn |
| Mar 31, 2018 | 37.00 Mn |
| Dec 31, 2017 | 21.00 Mn |
| Dec 31, 2017 | 21.00 Mn |
| Sep 30, 2017 | -18.00 Mn |
| Sep 30, 2017 | -18.00 Mn |
| Jun 30, 2017 | -8.00 Mn |
| Jun 30, 2017 | -8.00 Mn |
| Mar 31, 2017 | 26.00 Mn |
| Mar 31, 2017 | 26.00 Mn |
| Dec 31, 2016 | -35.00 Mn |
| Dec 31, 2016 | -35.00 Mn |
| Sep 30, 2016 | 22.00 Mn |
| Sep 30, 2016 | 22.00 Mn |
| Jun 30, 2016 | -1.00 Mn |
| Jun 30, 2016 | -1.00 Mn |
| Mar 31, 2016 | 43.00 Mn |
| Mar 31, 2016 | 43.00 Mn |
| Dec 31, 2015 | -19.00 Mn |
| Dec 31, 2015 | -19.00 Mn |
| Sep 30, 2015 | 9.00 Mn |
| Sep 30, 2015 | 9.00 Mn |
| Jun 30, 2015 | -20.00 Mn |
| Jun 30, 2015 | -20.00 Mn |
| Mar 31, 2015 | 66.00 Mn |
| Mar 31, 2015 | 66.00 Mn |
| Dec 31, 2014 | -11.00 Mn |
| Dec 31, 2014 | -11.00 Mn |
| Sep 30, 2014 | 1.00 Mn |
| Sep 30, 2014 | 1.00 Mn |
| Jun 30, 2014 | -61.00 Mn |
| Jun 30, 2014 | -61.00 Mn |
| Mar 31, 2014 | 18.00 Mn |
| Mar 31, 2014 | 18.00 Mn |
| Dec 31, 2013 | 10.00 Mn |
| Dec 31, 2013 | 10.00 Mn |
| Sep 30, 2013 | 25.00 Mn |
| Sep 30, 2013 | 25.00 Mn |
| Jun 30, 2013 | -4.00 Mn |
| Jun 30, 2013 | -4.00 Mn |
| Mar 31, 2013 | -97.00 Mn |
| Mar 31, 2013 | -97.00 Mn |
| Dec 31, 2012 | -139.00 Mn |
| Dec 31, 2012 | -139.00 Mn |
| Sep 30, 2012 | -4.00 Mn |
| Sep 30, 2012 | -4.00 Mn |
| Jun 30, 2012 | 1.00 Mn |
| Jun 30, 2012 | 1.00 Mn |
| Mar 31, 2012 | -9.00 Mn |
| Mar 31, 2012 | -9.00 Mn |